Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model

Gibani MM. et al, (2020), PLOS Neglected Tropical Diseases, 14, e0008783 - e0008783

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (vol 396, pg 467, 2020)

Folegatti PM. et al, (2020), LANCET, 396, 466 - 466

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478

An evaluation of rectal artesunate for the pre-hospital management of severe malaria.

Angus BJ., (2020), Expert opinion on pharmacotherapy, 1 - 7

Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model

Jin C. et al, (2019), PLOS Neglected Tropical Diseases, 13, e0007955 - e0007955

Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): a protocol for a longitudinal cohort study.

Peterson I. et al, (2019), BMJ Open, 9

Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization

Peterson RL. et al, (2019), Contemporary Clinical Trials Communications, 15

Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.

Gibani MM. et al, (2019), Nat Med

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.

Green CA. et al, (2019), J Infect, 78, 382 - 392

The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.

Gibani MM. et al, (2019), Clin Infect Dis, 68, 1265 - 1273

Osh Infection in the Immunocompromised Host

Fox S. et al, (2019)

Oral versus Intravenous Antibiotics for Bone and Joint Infection.

Li H-K. et al, (2019), N Engl J Med, 380, 425 - 436

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.

Lacerda MVG. et al, (2019), N Engl J Med, 380, 215 - 228

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.

Llanos-Cuentas A. et al, (2019), The New England journal of medicine, 380, 229 - 241

Prime and target immunization protects against liver-stage malaria in mice

Gola A. et al, (2018), Science Translational Medicine, 10, eaap9128 - eaap9128

Davidson's Principles and Practice of Medicine

Ralston S. et al, (2018)

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP.

Rampling T. et al, (2018), NPJ Vaccines, 3

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Jin C. et al, (2017), Lancet, 390, 2472 - 2480

Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka.

Franzen SRP. et al, (2017), BMJ Open, 7

Response to the editorial by Dr Geraghty.

White PD. et al, (2017), J Health Psychol, 22, 1113 - 1117

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?